Stacy L ChinFounder, KeepYourEquity · I get the government to write you checks

Founders: Don’t Miss This $144M ARPA-H Program

8 Apr 2026 · 1 min

Watch on YouTube

0:34

In this brief announcement, the speaker alerts biotech founders to a newly announced ARPA-H funding opportunity called the STOMP program, which allocates $144 million to develop technologies for detecting and monitoring microplastics in the body (lungs, brain, arteries, etc.). The speaker frames microplastic measurement as a critical, unsolved problem and emphasizes that the program’s goal is to fund solutions that address this measurement gap. A hard deadline of May 6 is highlighted, and founders working on biosensors, diagnostics, or novel materials are urged to consider applying or to contact the speaker directly for assistance.

Chapters

$144 million just dropped from ARPA-H, but most biotech founders are going to miss this, and you only have until May 6th to get your idea in front of them. Microplastics are everywhere, including the lungs, the brains, the arteries. So ARPA-H's program called STOMP is focused on detecting and monitoring these microplastics. But here's the real issue: we can't properly monitor them. And that's exactly what this program is funding. And this is a measurement problem with $144 million behind it. So if you're building in biosensors, diagnostics, or materials, this is your lane. So So even if you're thinking of pursuing this opportunity, make sure to DM me because—